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INTRODUCTION
Radiotherapy-induced increased generation of reac-
tive oxygen species (ROS) exceeding the protec-
tive capacity of the antioxidant and DNA repair 
system causes death of cancer cells, but also has 
toxic side effects on healthy tissues (Nair et al., 
2001). Moreover, differences in the activities of 
AO enzymes may be associated with the complex 
phenomena of radiosensitivity and radioresistance. 
Increase of both malignancy and radiosensitiv-
ity were shown to be associated with decrease of 
MnSOD and GPx activities, as well as GSH content, 
in rat epithelial cell lines (Bravard et al., 2002). In a 
radioresistant variant clone from a human glioblas-
toma cell line, the activities of SOD, CAT, GPx, and 
GR were found to be activated up to five-fold when 
compared to the parent cells after irradiation (Lee et 
al., 2004). In addition, severe side effects commonly 
arising from radiotherapy often prevent patients 
from completing the treatment course and largely 
determine the quality of life following radiotherapy. 
Estimation of oxidative damage and the AO defense 
capacity of healthy tissues in the response to radio-
therapy can therefore contribute to the development 
of successful radioprotection strategies. Our previ-
ous research showed that the activity of MnSOD 
is inversely correlated with the yield of γ-radia-
tion–induced micronuclei in vitro in human blood 
lymphocytes, suggesting a base for a rapid predictive 
assay of radiosensitivity in a clinical setting (Pajović 
et al., 2000). Our results also showed that activity of 
SOD, particularly MnSOD, significantly contributes 
to the relative biological effectiveness of proton irra-
diation in vitro as measured by the dose-dependent 
production of dicentrics and micronuclei in human 
lymphocytes (Joksić et al., 2000). 
By initiating autocatalytic lipid peroxidation, 
ROS generate a large variety of potential toxic 
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products (such as LP) that are often used as mark-
ers of lipid peroxidation and oxidative stress in 
human pathology and toxicology (Mayne, 2003). 
Superoxide dismutase catalyzes dismutation of the 
superoxide radical (O2•-) into H2O2, which is fur-
ther decomposed by the action of CAT and GPx 
(Ambrosone, 2000). In conjunction with GPx, GSH 
detoxifies peroxides and a wide range of xenobiot-
ics and carcinogens. Restoration of reduced GSH 
is made possible by GR (Abou Ghalia and Fouad, 
2000).
Cancer is among the degenerative diseases asso-
ciated with aging, which also include cardiovascular 
disease, immune-system decline, brain dysfunc-
tion, and cataracts. The functional degeneration of 
somatic cells during aging appears, in good part, to 
contribute to these diseases. Although ROS (oxida-
tive stress) are recognized to play a significant role 
in breast carcinogenesis (Ambrosone, 2000; Kang, 
2002), as well as in the aging process (Droge, 2003), 
we found no published data regarding age-related 
modulation of oxidative stress and the AO system 
in breast cancer radiotherapy. In this work, we 
therefore investigated the effects of radiotherapy on 
activities of AO enzymes (CuZnSOD, CAT, GPx, 
and GR), GSH concentration in blood cells, and 
LP concentration in blood plasma in breast cancer 
patients of different ages.
MATERIALS AND METHODS
The study included breast cancer patients from 
the Institute of Oncology and Radiology of Serbia, 
Belgrade, divided according to their age into two 
age groups, 45-58 years (n=7, median age 51.3) 
and above 60 years (n=9, median age 69.4). All of 
them were newly diagnosed and clinically classi-
fied as patients in stages IIIA (n=11) and IIIB (n=5) 
according to the system of the International Union 
Against Cancer (UICC) (1997). Breast cancer cases 
were further classified as T2N2M0 (n=9), T3N2M0 
(n=2), and T4bN1M0 (n=5), and tumors were 
histologically diagnosed as invasive ductal (n=8), 
invasive lobular (n=6), and medullary (n=2) carci-
nomas. All patients in the age group of 45-58 years 
were peri-menopausal, whereas patients older than 
60 years were post-menopausal. Patient characteris-
tics according to their age are presented in Table 1. 
Patients were submitted to radiotherapy with a total 
dose of 45-51 Gy and fraction size of 3 Gy for breast 
tumors, and with a total dose of 45 Gy and fraction 
size of 3 Gy for regional lymphatics, over a period 
of 6 weeks (Linear Accelerator, 6 MeV). In accor-
dance with the ethical guidelines of the Helsinki 
Declaration, informed consent was obtained from 
all participants.
Heparinized venous blood specimens were 
obtained on the day of the beginning of the radio-
therapy regimen and 24 h after its completion. 
Blood specimens were centrifuged at 2500g for 5 
min at 4oC (Eppendorf centrifuge 5417, Eppendorf 
AG, Hamburg, Germany). Plasma samples were 
collected, kept at -700C, and after defrosting centri-
fuged at 11000g for 1 min at 4oC. Clarified plasma 
preparations were used for LPO assay. Blood cells 
from pellets were washed two times in cold 0.9% 
NaCl and lyzed in 2 volumes of ice-cold demineral-
ized ultrapure water (MilliQ reagent grade water 
system, Millipore Corp., Bedford, MA, USA), after 
which the crude lyzate was kept frozen at -70oC 
before being used for blood cell extracts and clari-
fied lyzate preparations. The crude lyzate was used 
for CAT and GPx assays and protein concentration 
measurements. Hemoglobin was removed from the 
crude lyzate by adding chloroform and ethanol (the 
lyzate: chloroform: ethanol volumetric ratio was 1: 
1: 0.6). After centrifugation at 3000g for 10 min at 
4oC (Eppendorf centrifuge 5417, Eppendorf AG, 
Hamburg, Germany), the upper aqueous layer was 
collected and used for CuZnSOD assay. Following 
blood cell stroma removal from the crude lyzate 
by centrifugation at 8600g for 10 min at 4oC, the 
clarified lyzate was used for GR assay. After protein 
precipitation from the crude lyzate (the lyzate: pre-
cipitation reagent volumetric ratio was 1: 3) and cen-
trifugation at 10000g for 5 min at room temperature, 
the supernatant was used for GSH assay.
Assays for CuZnSOD, GPx, GR, GSH, and LPO 
were performed using methods and reagents from 
BioxytechR Assays (OXIS International Inc., Portland, 
OR, USA). The unit of SOD activity was defined as 
the amount of enzyme that doubles the autooxida-
tion rate of the control blank under the assay condi-
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tions. The unit of GPx activity and GR activity was 
defined as 1 μmol of NADPH oxidized per minute 
under the assay conditions. Determination of CAT 
activity was performed by the method of Beutler 
(1982). The unit of CAT activity was defined as 1 
μmol of H2O2 decomposed per minute under the 
method conditions. The enzyme assays and con-
centration measurements were monitored spectro-
photometrically (Perkin Elmer spectrophotometer, 
λ25, Perkin Elmer Instruments, Norwalk, CT, USA). 
Enzyme activities were expressed in U or mU per 
milligram of total cell protein (U or mU/mg protein). 
Concentrations of GSH and LPO were expressed in 
nmol/mg protein and pmol/mg of protein, respec-
tively. Determination of protein concentration was 
performed by the method of Lowry et al. (1951) and 
expressed in mg/ml.
Statistical analyses were performed using the 
Origin 7.0 statistical package. Data were compared by 
the Student’s paired t-test at a statistical significance 
level of p<0.05 and expressed as means ± SEM.
RESULTS 
The results indicate that the AO status in patients’ 
blood 24 h after the breast cancer radiotherapy regi-
men was completed differed significantly from the 
values before radiotherapy (Fig. 1). In patients aged 
45-58 years, radiotherapy increased the activities of 
CuZnSOD (2.48±0.39 vs. 2.73±0.34 U/mg of prot., 
p<0.05), CAT (95.73±9.03 vs. 112.97±8.49 U/mg of 
prot., p<0.05), and GR (3.66±0.32 vs. 3.94±0.36 mU/
mg of prot., p<0.05), as well as concentration of GSH 
(5.67±0.58 vs. 6.83±0.52 nmol/mg of prot., p<0.05). 
In this age group, GPx activity remained unchanged 
after radiotherapy (17.14±0.47 vs. 17.26±1.0 mU/
mg of prot., p>0.05), and the concentration of LP 
was also steady (72.20±5.58 vs. 74.19±9.57 pmol/mg 
of prot., p>0.05). 
As in younger ones, radiotherapy in patients older 
than 60 years increased the activities of CuZnSOD 
(3.09±0.21 vs. 3.48±0.22 U/mg of prot., p<0.05) and 
CAT (95.04±6.47 vs. 107.74±5.29 U/mg of prot., 
p<0.05), but simultaneously decreased the activity 
of GPx (17.46±0.50 vs. 14.65±0.93 mU/mg of prot., 
p<0.05) and the concentration of GSH (6.04±0.62 
vs. 5.04±0.51 nmol/mg of prot., p<0.05). In this age 
group, radiotherapy did not significantly affect the 
activity of GR (3.53±0.38 vs. 3.00±0.29 mU/mg of 
prot., p>0.05), whereas it increased the concentra-
tion of LP (70.66±5.61 vs. 80.32±3.69 pmol/mg of 
prot., p<0.05).
DISCUSSION
Our results showed that the AO response to radio-
therapy in the blood of breast cancer patients was 
significantly different in the examined age groups. 
In the patients aged 45 to 58 years, oxidative stress 
was not detected after radiotherapy, to judge from 
Age group 45-58 years (n=7) above 60 years (n=9)
Median age
(years, range) 51 (48-58) 69 (62-78)
Clinical stage
Stage IIIA T2N2M0 4 5
 T3N2M0 1 1
Stage IIIB T4bN1M0 2 3
Histological type
Invasive ductal 3 5
Invasive lobular 2 4
Medullary 2 0
Menopausal status
Peri-menopausal 7 0
Post-menopausal 0 9
Table 1. Breast cancer patient characteristics.
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the unchanged concentration of LP. At the same 
time, increased GR activity indicates increased pro-
duction of reduced GSH, which is in accordance 
with its increased concentration in the blood. These 
results imply that increased activities of SOD and 
CAT, as well as increased concentration of reduced 
GSH, are sufficient for elimination of elevated O2•- 
and H2O2 production and suppression of oxida-
tive stress induced by radiotherapy in the blood of 
younger patients.
In patients above the age of 60, radiotherapy 
induced occurrence of lipid oxidative damage. In 
this age group, the activities of CuZnSOD and CAT 
were increased after radiotherapy (as in younger 
patients), but the activity of GPx and GSH concen-
tration were found to be significantly lowered. Based 
on this, it would appear that decreased capacity for 
H2O2 elimination might be a cause of the detected 
oxidative damage. Hydrogen peroxide in increased 
concentrations, apart from causing direct oxida-
tive damage, can generate extremely reactive •OH 
radicals through interaction with transitional metals 
(Stohs and Bagchi, 1995). In addition to the radio-
therapy-induced suppression of H2O2 detoxification 
reported in this work, human tumor cells were found 
to produce increased amounts of H2O2, keeping 
them under persistent oxidative stress (Szatrowski 
and Nathan, 1991). Breast cancer may also create 
systemic conditions that increase the level of H2O2 
in circulating cells. Such systemic conditions may 
favor survival and further invasion of breast cancer 
cells (Adžić et al., 2006). 
Free radicals and peroxides can be directly 
removed by the action of reduced GSH, which is 
Fig. 1. Antioxidant enzyme activities and concentration of GSH and LP in the blood of breast cancer patients in the examined age 
groups before (A) and after (B) radiotherapy. The data are given in mean values ± SEM, * p<0.05 (Student’s paired t-test).
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the main endogenous soluble antioxidant in mam-
malian cells (Balendiran et al., 2004). Reduced 
glutathione can act through formation of a disulfide 
mixture or by oxidation to GSSG, thus preventing 
damaging effects on tissues caused by peroxidation 
of membrane lipids (Toborek and Henning, 1994). A 
decreased level of GSH may cause increased oxida-
tive damage to lipids, both through impairment of 
its direct antioxidative actions and through indirect 
influence via decreasing GPx activity where it is 
necessary as a co-substrate (Abou Ghalia and Fouad, 
2000), both of which were recorded in patients 
above 60 years. Since the reduced activity of GR 
found in older patients, although not significant, 
coincides with a lowered concentration of GSH, it 
suggests a reduced level of GSH regeneration by GR 
in this age group.
Our results indicate that the response to radio-
therapy includes age-related decrease of AO capacity 
for elimination of H2O2, thus causing the occurrence 
of oxidative damage to blood cells in progressive 
stages of breast carcinoma. This suggests that cyto-
toxic radiation effects on healthy tissues, induced 
by increased ROS production and causing oxidative 
damage to biomolecules, may significantly interfere 
with cell homeostasis in older patients with breast 
cancer as a consequence of the already present sup-
pression of the AO system during the aging process. 
In a recently published work, we observed a deleteri-
ous contribution of the aging process to increase of 
oxidative stress, decrease of AO enzyme activities 
and concentration of GSH, and decrease of cytosol 
SOD enzyme expression in progressive stages of 
breast carcinomas. These results strongly emphasize 
the rising need for additional antioxidant support 
throughout the advancing aging process, particu-
larly in middle-aged and elderly women with higher 
risk of breast carcinomas (Kasapović et al., 2008). To 
sum up, it may be important to consider circulating 
levels of antioxidants in predicting a woman’s risk 
of breast cancer and individualizing breast cancer 
radiotherapy protocols (Pajović et al., 2000, 2003). 
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У овом ра­ду ис­питива­ли с­мо ефек­те ра­дио­
тера­пије к­а­н­цера­ дојк­е н­а­ а­к­тивн­ос­т а­н­тиок­с­и­
да­тивн­их (АО) ен­зима­, ба­к­а­р, цин­к­ с­уперок­с­ид 
дис­мута­зе (CuZnSOD), к­а­та­ла­зе (CAT), глута­­
тион­ перок­с­ида­зе (GPx) и глута­тион­ редук­та­­
зе (GR), к­а­о и н­а­ к­он­цен­тра­цију редук­ова­н­ог 
глута­тион­а­ (GSH) и липидн­их перок­с­ида­ (LP) 
у к­рви па­цијен­тк­иња­ с­та­рих од 45­58 годин­а­ и 
с­та­ријих од 60 годин­а­. Резулта­ти пок­а­зују да­ у 
к­рви па­цијен­тк­иња­ с­та­рих 45­58 год., ра­диотера­­
пија­ ин­дук­ује повећа­ње а­к­тивн­ос­ти CuZnSOD, 
CAT и GR, к­а­о и к­он­цен­тра­ције GSH и н­е ути­
че н­а­ а­к­тивн­ос­т GPx и к­он­цен­тра­цију LP. Код 
па­цијен­тк­иња­ с­та­ријих од 60 год., ра­диотера­пија­ 
ин­дук­ује повећа­ње а­к­тивн­ос­ти CuZnSOD и CAT, 
с­н­ижење а­к­тивн­ос­ти GPx и к­он­цен­тра­ције GSH, 
к­а­о и повећа­ње к­он­цен­тра­ције LP. На­ши резулта­­
ти ук­а­зују да­ ра­диотера­пијс­к­и одговор ук­ључује 
с­н­ижење АО к­а­па­цитета­ за­ ук­ла­ња­ње H2o2 к­оје 
је веза­н­о за­ с­та­рос­т, узрок­ујући ок­с­ида­тивн­а­ 
оштећења­ у ћелија­ма­ к­рви. Ово с­угерише да­ 
цитоток­с­ичн­и ефек­а­т ра­дија­ције н­а­ здра­ва­ тк­ива­ 
може бити изра­жен­ији ток­ом с­та­рења­ па­цијен­т­
к­иња­ с­а­ к­а­н­цером дојк­е и треба­ло би га­ узети у 
обзир прилик­ом да­љег ра­звоја­ ин­дивидуа­лиза­ци­
је проток­ола­ у ра­диотера­пији к­а­н­цера­.
